Nicole Marra-Schneiderhan

Tuebingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications

Peripheral Immune Challenge Drives Enteric α-Synuclein and Tau Pathology in LRRK2 G2019S Mice.

Peripheral Immune Challenge Drives Enteric α-Synuclein and Tau Pathology in LRRK2 G2019S Mice.

Journal: Aging and disease
Published: March 25, 2026

Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageing.

Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageing.

Journal: Parkinsonism & related disorders
Published: October 31, 2025

Polyelectrolyte Multilayer Coatings As a Tunable Tool to Control Inflammatory Response to Biomaterials in Vitro.

Polyelectrolyte Multilayer Coatings As a Tunable Tool to Control Inflammatory Response to Biomaterials in Vitro.

Journal: ACS applied bio materials
Published: October 28, 2025

Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens.

Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens.

Journal: Cells
Published: September 25, 2025

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Journal: Vaccines
Published: May 24, 2025

Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees.

Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 05, 2025

Cross-sectional evaluation of host biomarkers for guiding antibiotic use in bacterial and non-bacterial acute febrile illness in low- and middle-income tropical settings.

Cross-sectional evaluation of host biomarkers for guiding antibiotic use in bacterial and non-bacterial acute febrile illness in low- and middle-income tropical settings.

Journal: BMJ open
Published: February 13, 2025

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Journal: Vaccines
Published: October 02, 2024

Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.

Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.

Journal: Journal of Parkinson's disease
Published: September 06, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics
Published: August 28, 2024

Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.

Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.

Journal: Frontiers in immunology
Published: August 13, 2024

Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families.

Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families.

Journal: Scientific reports
Published: August 01, 2024
Showing 1-12 of 86

Last Updated: 09/26/2026